MET and neoplasm: In a murine model of melanoma, the inhibition of the receptor tyrosine kinase c-MET (HGF-R, hepatocyte growth factor receptor) reduces neutrophil recruitment in the tumor microenvironment and in the draining lymph nodes in response to immunotherapy (Figure 2).